Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Standard BioTools
LAB
$256M
| $2.27M | 0.01% |
891,915
+754,991
| +551% | +$2.48M |
|
1902
PRA Group
PRAA
$732M
| $2.26M | 0.01% |
+81,561
| New | +$2.84M |
|
1903
CALL
Starbucks
SBUX
$124B
| $2.26M | 0.01% |
34,400
-122,900
| -78% | -$9.94M |
|
1904
OneSpaWorld
OSW
$2.69B
| $2.26M | 0.01% |
+556,654
| New | +$6.7M |
|
1905
CytomX Therapeutics
CTMX
$723M
| $2.26M | 0.01% |
294,313
-29,669
| -9% | -$207K |
|
1906
Manulife Financial
MFC
$71.7B
| $2.25M | 0.01% |
+179,458
| New | +$3.12M |
|
|
ACR
1907
ACRES Commercial Realty
ACR
$102M
| $2.25M | 0.01% |
271,245
+92,151
| +51% | +$2.79M |
|
1908
CALL
Morgan Stanley
MS
$336B
| $2.24M | 0.01% |
65,800
-91,900
| -58% | -$4.33M |
|
1909
DXP Enterprises
DXPE
$2.96B
| $2.23M | 0.01% |
+182,311
| New | +$5.26M |
|
1910
Roku
ROKU
$23.5B
| $2.23M | 0.01% |
25,429
-175,649
| -87% | -$20.2M |
|
|
P
1911
Everpure Inc
P
$36.2B
| $2.22M | 0.01% |
180,591
+143,014
| +381% | +$2.32M |
|
1912
UNIFI
UFI
$140M
| $2.22M | 0.01% |
192,246
+181,609
| +1,707% | +$3.73M |
|
|
I
1913
CALL
DELISTED
INTELSAT S. A.
I
| $2.22M | 0.01% |
1,450,000
+150,000
| +12% | +$628K |
|
|
JWN
1914
DELISTED
Nordstrom
JWN
| $2.22M | 0.01% |
144,547
-165,571
| -53% | -$5.52M |
|
1915
DigitalBridge
DBRG
$2.95B
| $2.21M | 0.01% |
316,109
+196,493
| +164% | +$3.12M |
|
|
CLLS
1916
Cellectis
CLLS
$344M
| $2.21M | 0.01% |
240,266
-76,012
| -24% | -$1.13M |
|
1917
Fulcrum Therapeutics
FULC
$295M
| $2.21M | 0.01% |
185,019
+94,838
| +105% | +$1.52M |
|
1918
Horizon Bancorp
HBNC
$1.01B
| $2.2M | 0.01% |
223,506
+72,282
| +48% | +$1.11M |
|
1919
PUT
Conagra Brands
CAG
$7.77B
| $2.2M | 0.01% |
75,100
-40,400
| -35% | -$1.22M |
|
1920
BGC Group
BGC
$5.66B
| $2.2M | ﹤0.01% |
872,890
-292,005
| -25% | -$1.43M |
|
1921
Smith Micro Software
SMSI
$16.6M
| $2.2M | ﹤0.01% |
13,057
+4,891
| +60% | +$974K |
|
1922
Xenon Pharmaceuticals
XENE
$6.18B
| $2.19M | ﹤0.01% |
193,569
+145,855
| +306% | +$2.08M |
|
|
LX
1923
LexinFintech Holdings
LX
$194M
| $2.19M | ﹤0.01% |
247,374
+185,999
| +303% | +$2.3M |
|
|
SNBR
1924
DELISTED
Sleep Number
SNBR
| $2.19M | ﹤0.01% |
114,434
-180,502
| -61% | -$8.04M |
|
|
BCEL
1925
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.19M | ﹤0.01% |
+132,203
| New | +$2.4M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.